The University of Chicago Header Logo

Connection

Francis J. Alenghat to Mineralocorticoid Receptor Antagonists

This is a "connection" page, showing publications Francis J. Alenghat has written about Mineralocorticoid Receptor Antagonists.
  1. A composite metric for predicting benefit from spironolactone in heart failure with preserved ejection fraction. ESC Heart Fail. 2021 10; 8(5):3495-3503.
    View in: PubMed
    Score: 0.195
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.